Polypeptide Group Ag (PLYGF)

$42.42 +7.03 (19.86%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 100
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally. It develops and manufactures synthetic peptides used as active pharmaceutical ingredients or intermediates in therapeutic products. The company offers portfolio of drug therapies for metabolic diseases, including the GLP-1. It also provides generic peptides and peptides used in cosmetics, animal health, and medical devices, as well as development and...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 41 435 020 580
Address:
Neuhofstrasse 24, Baar, Switzerland
DonCorleone77
DonCorleone77 Apr. 13 at 10:41 AM
$PLYGF $EQBBF $KKR PolyPeptide is attracting takeover interest from EQT, KKR, Bloomberg says PolyPeptide Group is attracting private equity takeover interest, with EQT (EQBBF), KKR (KKR), and Advent among suitors looking into a potential acquisition of the company, Dinesh Nair, Allegra Catelli, and Manuel Baigorri of Bloomberg reports, citing people with knowledge of the matter.
0 · Reply
Latest News on PLYGF
No data available.
DonCorleone77
DonCorleone77 Apr. 13 at 10:41 AM
$PLYGF $EQBBF $KKR PolyPeptide is attracting takeover interest from EQT, KKR, Bloomberg says PolyPeptide Group is attracting private equity takeover interest, with EQT (EQBBF), KKR (KKR), and Advent among suitors looking into a potential acquisition of the company, Dinesh Nair, Allegra Catelli, and Manuel Baigorri of Bloomberg reports, citing people with knowledge of the matter.
0 · Reply